Lymph node dissection in the surgical management of stage I endometrial carcinomas;La lymphadénectomie dans les cancers de l'endomètre de stade I

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 12, 2003, Pages 1004-1012

  Querleu, D ^a   Leblanc, E ^b   Martel, P ^a   Ferron, G ^a   Narducci, F ^b  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

Endometrial carcinoma; Lymph node dissection

Indexed keywords

CANCER RADIOTHERAPY; ENDOMETRIUM CARCINOMA; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MORBIDITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW; SURGICAL RISK;

EID: 0842324885     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2003.06.003     Document Type: Article

References (65)

1. Girardi F., Petru E., Heydarfadai M., Haas J., Winter R. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol. 49:1993;177-180.
2. Reich O., Winter R., Pickel H., Tamussino K., Haas J., Petru E. Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer? Int J Gynecol Cancer. 6:1996;445-447.
3. Arango H.A., Hoffman M.S., Roberts W.S., De Cesare J.L.L., Fiorica J.V., Drak J. Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet Gynecol. 95:2000;553-556.
4. Chuang L., Burke T.W., Tornos C., Marino B.D., Mitchell Mf., Tortolero-Luna G., et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 58:1995;189-193.
5. Burke T.W., Levenback C., Tornos C., Morris M., Wharton J.T., Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 62:1996;169-173.
6. Henriksen E. The lymphatic dissemination in endometrial carcinoma: a study of 188 necropsies. Amer J Obstet Gynecol. 123:1975;570-576.
7. Lécuru F., Neji K., Robin F., Darles C., De Bièvre P., Taurelle R. Drainage lymphatique de l'utérus. Résultats préliminaires d'une étude expérimentale. J Gynecol Obstet Biol Reprod. 26:1997;418-423.
8. Mariani A., Webb M.J., Keeney G.L., Podratz K.C. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol. 81:2001;100-104.
9. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B. Surgical pathologic spread patterns of endometrial cancer. Cancer. 60:1987;2035-2041.
10. Standards, options et recommandations. Cancers de l'endomètre, stades non métastatiques. 2001;John Libbey Eurotext, Paris.
11. Gal D., Recio Fo., Zamurovic D. The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma. Cancer. 69:1992;200-202.
12. Lampe B., Kurzl R., Hantschmann R. Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma. Cancer. 74:1994;2502-2508.
13. Mangioni C., De Palo G., Marubini E., Del Vecchio M. Surgical pathologic staging in apparent stage I endometrial carcinoma. Int J Gynecol Cancer. 3:1993;373-384.
14. Mariani A., Webb M.J., Keeney G.L., Lesnick T.G., Podratz K.C. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol. 87:2002;274-280.
15. Takeshima N., Hirai Y., Tanaka N., Yamawaki T., Yamauchi K., Hasumi K. Pelvic lymph node metastasis in endometrial cancers with no myometrial invasion. Obstet Gynecol. 88:1996;280-282.
16. Kinkel K., Kaji Y., Yu K.K., Segal M.R., Lu Y., Powell C.B., Hricak H. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology. 212:1999;711-718.
17. Atad J., Weill S., Ben-David Y., Hallak M., Klein O., Lurie M., et al. Intraoperative frozen section examination of myometrial invasion depth in patients with endometrial carcinoma. Int J Gynecol Cancer. 4:1994;352-355.
18. Noumoff J.S., Menzin A., Mikuta J., Lusk E.J., Morgan M., Livolsi V.A. The ability to evaluate prognostic variables on frozen section in hysterectomies performed for endometrial carcinoma. Gynecol Oncol. 42:1991;202-208.
19. Mariani A., Webb M.J., Keeney G.L., Haddock M.G., Calori G.M.S., Podratz K.C. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 182:2000;1506-1519.
20. Orr J.W., Roland P.Y., Leichter D., Orr P.F. Endometrial cancer: is surgical staging necessary? Curr Opin Oncol. 13:2001;408-412.
21. Petersen R.W., Quinlivan J.A., Casper G.R., Nicklin J.L. Endometrial adenocarcinoma: presenting pathology is a poor predictor to surgical management. Austr N Z J Obstet Gynaecol. 40:2000;191-194.
22. Cohn D.E., Horowitz N.S., Mutch D.G., Kim S.M., Manolitsas T., Fowler J.M. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol. 87:2002;423-426.
23. Kolbenstveldt A., Kolstad P. The difficulties of complete pelvic lymph node dissection in radical hysterectomy for carcinoma of the cervix. Gynecol Oncol. 4:1976;244-254.
24. Benedetti-Panici P., Maneschi F., Cutillo G. Pelvic and aortic lymphadenectomy. Surg Clin North Am. 81:2001;841-858.
25. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. Gynecol Oncol. 40:1991;55-65.
26. Lanvin D., Elhage A., Henry B., Leblanc E., Querleu D., Delobelle-Deroide A. Accuracy and safety of laparoscopic lymphadenectomy. An experimental prospective randomized study. Gynecol Oncol. 67:1997;83-87.
27. Childers J.M., Brzechffa R.P., Hatch K.D., Surwit E.A. Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol Oncol. 51:1993;33-38.
28. Orr J.W., Holimon J.L., Orr P.L. Stage I corpus cancer: is teletherapy necessary? Amer J Obstet Gynecol. 176:1997;777-788.
29. Corn B.W., Lanciano R.M., Greven K.M., Noumoff J., Schultz D., Hanz G.E., et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol. 12:1994;510-515.
30. Pelvic lymphadenectomy in high-risk endometrial cancer. Int J Gynecol Cancer. 6:1996;102-107.
31. Haie-Meder C., Pejovic M.H., Gerbaulet A., Horiot J.C., Pourquier H., Delouche J., et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol. 11:1983;101-112.
32. Rotman M., Pajak T.F., Choi K., Clery M., Marcial V., Grigsby P.W., et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical cancer. Ten-year treatment results of RTOG 79-20. JAMA. 274:1995;387-393.
33. Mohan D.S., Samuels M.A., Selim M.A., Shalodi A.D., Ellis Rjj., Samuels J.R., et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 70:1998;165-171.
34. Franchi M., Ghezzi F., Riva C., Miglierina M., Buttarelli M., Bpolis F. Postoperative complications after pelvic lymphadenectomy for surgical staging of endometrial cancer. J Surg Oncol. 78:2001;232-237.
35. Otsuka I., Kubota T., Aso T. Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy. Brit J Cancer. 87:2002;377-380.
36. Potish R.A., Twiggs L.B., Adcock L.L., Savage J.E., Levitt S.H., Prem K.A. Paraaortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol. 65:1985;251-257.
37. Corn B.W., Lanciano R.M., Greven K.M., Schultz D.J.J., Reisinger S.A., Stafford P.M., et al. Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure. Int J Rad Oncol Biol Phys. 24:1992;223-227.
38. Rose P.G., Cha S.D., Tak W.K., Fitzgerald T., Reale F., Hunter R.E. Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma. Int J Rad Oncol Biol Phys. 24:1992;229-233.
39. Kadar.
40. Homesley H.D., Kadar N., Barrett R.J., Lentz S.S. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Amer J Obstet Gynecol. 167:1992;1225-1230.
41. Larson D.M., Johnson K., Olson K.A. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer. Morbidity and mortality. Obstet Gynecol. 79:1992;998-1001.
42. Kilgore L.C., Partridge E.E., Alvarez R.D., Austin J.M., Shingleton H.M., Noojin F., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 56:1995;29-33.
43. Mariani A., Webb M.J., Galli L., Podratz K.C. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol. 76:2000;348-356.
44. McMeekin, Lashbrook D., Gold M., Scribner Dr., Kamelle S., Tillmanns T.D., et al. Nodal distribution and its significance in FIGO sage IIIc endometrial cancer. Gynecol Oncol. 82:2001;375-379.
45. Seago D.P., Raman A., Lele S. Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers. Gynecol Oncol. 83:2001;282-285.
46. Podratz Kc., Mariani A., Webb Mj. Staging and therapeutic value of lymphadnectomy in endometrial cancer. Gyneco Oncol. 70:1998;163-164.
47. Straughn J.M., Huh W.K., Kelly J., Leath C.A., Kelinberg M.J., Hyde J., et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol. 84:2002;194-200.
48. Belinson J.L., Lee K.R., Badger G.J., Pretorius R.G., Jarrell M.A. Clinical stage I adenocarcinoma of the endometrium. Analysis of recurrences and the potential benefits of staging lymphadenectomy. Gynecol Oncol. 44:1992;17-23.
49. Calais G., Le Floch O., Descamps P., Vity L., Lansac J. Radical hysterectomy for stage I and II endometrial carcinoma: a retrospective analysis of 179 cases. Int J Rad Oncol Biol Phys. 20:1991;677-683.
50. Descamps P., Body G., Calais G., Moire C., Fignon A., Jourdain O., et al. Cancer de l'endomètre stade I et II: faut-il encore effectuer des lymphadénectomies ? J Gynecol Obstet Biol Repr. 24:1995;794-801.
51. Creutzberg C.L., Van Putten W.L., Koper P.C., Lybeert M.L., Jobsen Jjj., Warlam-Rodenhuis C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-I endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Postoperative Radiation Therapy in Endometrial Carcinoma. Lancet. 355:2000;1404-1411.
52. Massi G., Savino L., Susini T. Vaginal hysterectomy versus abdominal hysterectomy for the treatment of stage I endometrial adenocarcinoma. Amer J Obstet Gynecol. 174:1996;1320-1326.
53. Chen S.S. Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri: no recurrence with only primary surgery. Cancer. 63:1989;1843-1845.
54. Aalders J., Abeler V., Kolstad P., Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol. 56:1980;419-426.
55. Faught W., Krepart G.V., Lotocki R., Heywood M. Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer? Gynecol Oncol. 55:1994;51-55.
56. Doering D.L., Barnhill D.R., Weiser E.B., Burke T.W., Woodward J.E., Park R.C. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial carcinoma. Obstet Gynecol. 74:1989;930-933.
57. Holub Z., Jabor A., Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol. 23:2002;53-57.
58. Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M., et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol. 80:2001;139-144.
59. Fishman A., Klein A., Zemer R., Zimlichan S., Bernheim J., Cohen I., et al. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. Gynecol Oncol. 77:2000;399-404.
60. Van Trappen O.O., Gyselman V.G., Lowe D.G., Ryan A., Oram D.H., Bosze P., et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet. 357:2001;13-20.
61. Horn L.C., Fischer U., Hockel M. Occult tumor cells in surgical specimens from cases of early cancer treated by liposuction-assisted nerve-sparing radical hysterectomy. Int J Gynecol Cancer. 11:2001;159-163.
62. Hermanek P., Hutter R.V., Sobin L.H., Wittekind C. Classification of isolated tumor cells and micrometastasis. Cancer. 86:1999;2668-2673.
63. Lanciano R.M., Corn B.W., Schultz D.J., Kramer C., Rosenblum N., Hogan W.L. The prognostic significance of surgical staging for carcinoma of the endometrium. Radiol Oncol. 28:1993;189-196.
64. Poulsen H.K., Jacobsen M., Bertelsen K., Andersen J.E., Ahrons S., Bock J., et al. Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases. Int J Gynecol Cancer. 6:1996;38-43.
65. Boronow R.C. Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge - a personal perspective. Gynecol Oncol. 66:1997;179-189.